What is the fair value of Absci Corp (NASDAQ-ABSI) stock?

The current fair value estimate for Absci Corp (NASDAQ-ABSI) is $6.12. This implies an estimated downside of 25.6% versus the current market price.

Is Absci Corp (NASDAQ-ABSI) undervalued or overvalued?

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 25.6% versus the current market price.

What is the analyst price target for NASDAQ-ABSI stock?

The available analyst price target for Absci Corp (NASDAQ-ABSI) is $13.78. The analyst target implies estimated upside of 67.4%.

How is the financial health of Absci Corp?

The current financial health read for Absci Corp (NASDAQ-ABSI) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

When is Absci Corp's next earnings date?

The next earnings date currently listed for Absci Corp (NASDAQ-ABSI) is August 11, 2026.

Does Absci Corp (NASDAQ-ABSI) pay dividends?

Based on the current data, dividend yield is 0.0%.

What is the P/E ratio for Absci Corp (NASDAQ-ABSI)?

The current P/E ratio listed for Absci Corp (NASDAQ-ABSI) is -11.7x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

What is the market capitalization of Absci Corp?

The current market capitalization listed for Absci Corp is 1.382 B.

What is the enterprise value of Absci Corp?

The current enterprise value listed for Absci Corp is 1.264 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

What is the ticker symbol for Absci Corp?

The ticker symbol for Absci Corp is NASDAQ-ABSI, and the stock is listed on NASDAQ.

Where is Absci Corp (NASDAQ-ABSI) listed?

Absci Corp (NASDAQ-ABSI) is listed on NASDAQ.

What is the debt-to-total-capital ratio for Absci Corp?

The current debt-to-total-capital ratio listed for Absci Corp is 0.3%, which helps investors evaluate the company’s financing structure and leverage profile.

What is the free float for Absci Corp?

The free float listed for Absci Corp is 95.4%. Free float helps investors understand how much of the share base is available for public trading.

Absci Corp (ABSI) Fair Value & Stock Analysis

Absci Corp (ABSI)

Absci Corporation is a clinical-stage biopharmaceutical company focused on developing antibody-based therapeutics in the United States. Its pipeline includes ABS-101, which is in Phase 1 testing for inflammatory bowel disease; ABS-201, an anti-prolactin receptor antibody in Phase 1/2a development for androgenic alopecia; ABS-301 for immuno-oncology; and ABS-501 for oncology. The company also works with a range of research and technology partners, including PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, Owkin, Oracle, and Advanced Micro Devices, on joint research and development efforts. Founded in 2011, Absci is headquartered in Vancouver, Washington, and its common stock trades on the NASDAQ under the symbol ABSI.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Fair Value Upside/Downside	Fair Value Rating	Analyst Price Target	Analyst Target Upside/Downside	Analyst Target Rating	Overall Financial Health	Upcoming Dividend Ex-Date	Dividend Payment Date	Upcoming Dividend	Dividend Yield	Next Earnings Date	P/E Ratio	Price-to-Book Ratio	Price-to-Sales Ratio	Market Cap	Enterprise Value	Total Debt / Total Capital	Free Float / Shares Outstanding	Altman Z-Score	Payout Ratio	Free Cash Flow / Net Income
NASDAQ-ABSI	$6.12	-25.6% Downside	Overvalued	$13.78	67.4% Upside	Bargain	Fair	—	—	—	0.0%	August 11, 2026	-11.7x	8.1x	754.7x	1.382 B	1.264 B	0.3%	95.4%	27.3	—	83.2%